Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact
"Oncostar" LLC
"Oncostar" LLC
Sotio Biotech Inc.
Eisai Inc.
AstraZeneca
H. Lee Moffitt Cancer Center and Research Institute
Stanford University
Pfizer
University of Virginia
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Providence Health & Services
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
Takeda
National Cancer Institute (NCI)
Eli Lilly and Company
University of California, San Diego
Sichuan Enray Pharmaceutical Sciences Company
Ohio State University Comprehensive Cancer Center
Menarini Group
Boehringer Ingelheim
Pfizer
Thomas Jefferson University
Black Diamond Therapeutics, Inc.
Health Hope Pharma
Boehringer Ingelheim
Boehringer Ingelheim
Dana-Farber Cancer Institute
Daiichi Sankyo
NantBioScience, Inc.
Tesaro, Inc.
BeiGene
Vanderbilt-Ingram Cancer Center
Pfizer
Hoffmann-La Roche
Hoffmann-La Roche
Sandoz
Hutchmed
Pfizer
University of Washington
Pfizer
GlaxoSmithKline
Pfizer
Pfizer
Genentech, Inc.
Avera McKennan Hospital & University Health Center